These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27078056)

  • 1. Design of tuberculosis vaccine trials under financial constraints.
    García-Basteiro AL; Ruhwald M; Lange C
    Expert Rev Vaccines; 2016 Jul; 15(7):799-801. PubMed ID: 27078056
    [No Abstract]   [Full Text] [Related]  

  • 2. Gates grant boosts tuberculosis vaccine research. US82.9 million dollars grant will double global spending on new tuberculosis vaccines.
    McCarthy M
    Lancet; 2004 Feb; 363(9408):537. PubMed ID: 14976970
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting report: 5th Global Forum on TB Vaccines, 20-23 February 2018, New Delhi India.
    Atmakuri K; Penn-Nicholson A; Tanner R; Dockrell HM
    Tuberculosis (Edinb); 2018 Dec; 113():55-64. PubMed ID: 30514514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.
    Marinova D; Gonzalo-Asensio J; Aguilo N; Martin C
    Expert Rev Vaccines; 2017 Jun; 16(6):565-576. PubMed ID: 28447476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative clinical trial designs to rationalize TB vaccine development.
    Ellis RD; Hatherill M; Tait D; Snowden M; Churchyard G; Hanekom W; Evans T; Ginsberg AM
    Tuberculosis (Edinb); 2015 May; 95(3):352-7. PubMed ID: 25802031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 4th Global Forum on TB Vaccines.
    Evans TG; Drager N; Xiao H; Yuan Z
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S1-2. PubMed ID: 27312403
    [No Abstract]   [Full Text] [Related]  

  • 8. The tuberculosis vaccine challenge.
    Brennan MJ
    Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of new tuberculosis vaccine in children.
    Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
    Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiantigenic subunitary vaccines against tuberculosis in clinical trials: Where do we stand and where do we need to go?
    Guapillo C; Hernández-Pando R; Flores-Valdez MA
    Hum Vaccin Immunother; 2016 May; 12(5):1193-5. PubMed ID: 27049797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
    Fletcher HA; Dockrell HM
    Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In search of a new paradigm for protective immunity to TB.
    Nunes-Alves C; Booty MG; Carpenter SM; Jayaraman P; Rothchild AC; Behar SM
    Nat Rev Microbiol; 2014 Apr; 12(4):289-99. PubMed ID: 24590243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvants in tuberculosis vaccine development.
    Moreno-Mendieta SA; Rocha-Zavaleta L; Rodriguez-Sanoja R
    FEMS Immunol Med Microbiol; 2010 Feb; 58(1):75-84. PubMed ID: 20002177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and hindrances in tuberculosis vaccine development.
    Doherty TM; Rook G
    Lancet; 2006 Mar; 367(9514):947-9. PubMed ID: 16546547
    [No Abstract]   [Full Text] [Related]  

  • 15. Fact and fiction in tuberculosis vaccine research: 10 years later.
    Kaufmann SH
    Lancet Infect Dis; 2011 Aug; 11(8):633-40. PubMed ID: 21798463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards new TB vaccines: What are the challenges?
    Dockrell HM
    Pathog Dis; 2016 Jun; 74(4):ftw016. PubMed ID: 26960944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of clinical models for the evaluation of human TB vaccines.
    O'Shea MK; McShane H
    Hum Vaccin Immunother; 2016 May; 12(5):1177-87. PubMed ID: 26810964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of new tuberculosis vaccines: a global perspective on regulatory issues.
    Brennan MJ; Fruth U; Milstien J; Tiernan R; de Andrade Nishioka S; Chocarro L;
    PLoS Med; 2007 Aug; 4(8):e252. PubMed ID: 17683198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis.
    Griffiths KL; Villarreal DO; Weiner DB; Khader SA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2649-2653. PubMed ID: 27322875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials.
    Arbues A; Aguilo JI; Gonzalo-Asensio J; Marinova D; Uranga S; Puentes E; Fernandez C; Parra A; Cardona PJ; Vilaplana C; Ausina V; Williams A; Clark S; Malaga W; Guilhot C; Gicquel B; Martin C
    Vaccine; 2013 Oct; 31(42):4867-73. PubMed ID: 23965219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.